Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took Vivotif, but did not refrigerate it; The patient took Vivotif, but did not refrigerate it; Case reference number US-BN-2024-002405 is a spontaneous case initially received from a healthcare professional via agency (reference number: USBAV24-2137) on 27-Aug-2024 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, reported as believed that the entire course was done, the patient took doses of Vivotif (batch number: unknown), at an unknown dose or route of administration, for an unknown indication. As reported, the patient took Vivotif but did not refrigerate it while taking it (explicitly coded as 'product storage error' and 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to the Vivotif vaccine. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240827-0d3703 to US-BAVARIAN NORDIC A/S-US-BN-2024-002405, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient of unspecified age did not refrigerate Vivotif while taking it which is considered as product storage error and product administration error. Product storage error and product administration error are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to the Vivotif vaccine. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error are both assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A female patient of unspecified age did not refrigerate Vivotif while taking it which is considered as product storage error and product administration error. Product storage error and product administration error are both considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to the Vivotif vaccine. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error are both assessed as not related to suspect product but to human factor. The case is non-serious. USBAV24-2137:
Comments: None